We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.66%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$9.13B
AUM Growth
+$334M
Cap. Flow
-$281M
Cap. Flow %
-3.08%
Top 10 Hldgs %
21.52%
Holding
2,368
New
73
Increased
154
Reduced
1,152
Closed
75

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$34.6M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$3.94M
3
CZR icon
Caesars Entertainment
CZR
+$3.71M
4
IAA
IAA, Inc. Common Stock
IAA
+$3.57M
5
RUN icon
Sunrun
RUN
+$3.42M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$22.2M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$15.9M
3
MSFT icon
Microsoft
MSFT
+$13.6M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$9.6M
5
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$9.15M

Sector Composition

Rank Sector Weight
1 Technology 22.17%
2 Healthcare 13.84%
3 Financials 12.41%
4 Consumer Discretionary 11.36%
5 Industrials 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PBI icon
1601
Pitney Bowes
PBI
$2.28B
$316K ﹤0.01%
59,521
-15,768
-21% -$72.8K
EB
1602
DELISTED
Eventbrite
EB
$315K ﹤0.01%
29,076
– –
RCUS icon
1603
Arcus Biosciences
RCUS
$3.67B
$315K ﹤0.01%
18,398
+2,753
+18% +$61.5K
OSPN icon
1604
OneSpan
OSPN
$624M
$315K ﹤0.01%
15,031
– –
QTRX icon
1605
Quanterix
QTRX
$135M
$315K ﹤0.01%
9,336
+1,464
+19% +$47.1K
TBPH icon
1606
Theravance Biopharma
TBPH
$878M
$314K ﹤0.01%
21,254
– –
ARVN icon
1607
Arvinas
ARVN
$589M
$314K ﹤0.01%
13,286
– –
JBSS icon
1608
John B. Sanfilippo & Son
JBSS
$1.01B
$313K ﹤0.01%
4,150
– –
PETQ
1609
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$313K ﹤0.01%
9,493
– –
AR icon
1610
Antero Resources
AR
$11.3B
$312K ﹤0.01%
113,611
– –
DK icon
1611
Delek US
DK
$4.18B
$311K ﹤0.01%
27,977
-5,309
-16% -$81.7K
MGNI icon
1612
Magnite
MGNI
$3.53B
$311K ﹤0.01%
44,834
– –
MCHB
1613
Mechanics Bancorp
MCHB
$3.79B
$311K ﹤0.01%
12,061
– –
TVTY
1614
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$310K ﹤0.01%
22,138
– –
KFRC icon
1615
Kforce
KFRC
$1.08B
$309K ﹤0.01%
9,613
– –
OXM icon
1616
Oxford Industries
OXM
$542M
$309K ﹤0.01%
7,657
– –
SHYF
1617
DELISTED
The Shyft Group
SHYF
$308K ﹤0.01%
16,327
– –
ACLS icon
1618
Axcelis
ACLS
$4.42B
$307K ﹤0.01%
13,934
– –
GOOD
1619
Gladstone Commercial Corp
GOOD
$641M
$306K ﹤0.01%
18,170
– –
IPAR icon
1620
Interparfums
IPAR
$3.7B
$306K ﹤0.01%
8,191
– –
XRN
1621
Chiron Real Estate Inc
XRN
$484M
$306K ﹤0.01%
4,530
– –
NRC icon
1622
NRC Health Common Stock
NRC
$471M
$305K ﹤0.01%
6,206
– –
ARCH
1623
DELISTED
Arch Resources, Inc.
ARCH
$304K ﹤0.01%
7,165
– –
ARCT icon
1624
Arcturus Therapeutics
ARCT
$223M
$304K ﹤0.01%
7,084
+1,040
+17% +$51.6K
HEES
1625
DELISTED
H&E Equipment Services
HEES
$303K ﹤0.01%
15,412
– –
63 64
65
66 67

Similar funds

Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
NAM
Nissay Asset Management Tokyo, Japan $18.9B AUM 27.21% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

MetLife Investment Management's Q3 2020 Portfolio in Review

As of Q3 2020, MetLife Investment Management held 2,368 positions worth $9.13B, up 3.8% from $8.79B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

MetLife Investment Management withdrew a net $281M in Q3 2020, closing 75 positions and reducing 1,152 holdings. Its most notable exit was Slack Technologies, Inc., an estimated $7.44M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, MetLife Investment Management opened a new position in Jazz Pharmaceuticals worth $4.53M.

  • MetLife Investment Management's largest Q3 2020 buy was Jazz Pharmaceuticals: 31,753 shares worth $4.53M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $34.6M increase.
  • MetLife Investment Management's biggest Q3 2020 reduction was Apple, cutting an estimated $22.2M.
  • MetLife Investment Management fully exited Slack Technologies, Inc. in Q3 2020, selling an estimated $7.44M.
  • MetLife Investment Management's ten largest holdings make up 22% of its $9.13B portfolio in Q3 2020.
  • MetLife Investment Management opened 73 new positions and closed 75 in Q3 2020.
  • MetLife Investment Management's portfolio value rose 3.8% quarter-over-quarter to $9.13B.

Based on MetLife Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.